Upcoming NIAMS R21 funding for ancillary studies using ongoing clinical study data, samples, and cohorts (no clinical trials)
NIAMS plans to issue an R21 funding opportunity for ancillary studies that leverage ongoing clinical cohorts, infrastructure, data, and biospecimens. Parent studies may be outside NIAMS, but the ancillary project must align with the NIAMS mission; clinical trials are not allowed. This is a pre-announcement and applications are not yet being accepted.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on ancillary studies that aim to leverage the resources from the ongoing parent clinical studies such as well-charact…
Funding Source
Awards & funding
Eligibility
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers